From: Reporting and methodologic quality of Cochrane Neonatal review group systematic reviews
QUOROM statement item * | Yes | No | Partially/ Unclear | |
---|---|---|---|---|
1. | Title identified as meta-analysis or SR | 0 (0) | 61 (100) | |
Abstract | ||||
2. | Structured format used | 61 (100) | 0 (0) | |
3. | Objectives stated | 37 (61) | 2 (3) | 22 (36) |
4. | Data sources reported | 61 (100) | 0 (0) | |
5. | Review methods reported | |||
Selection criteria | 61 (100) | 0 (0) | ||
Validity assessment | 4 (7) | 57 (93) | ||
Data abstraction | 7 (11) | 54 (89) | ||
Study characteristics | 1 (2) | 60 (98) | ||
Data synthesis | 36 (59) | 25 (41) | ||
6. | Results | |||
Characteristics of studies | 6 (11) | 47 (89) | ||
Quantitative findings | 45 (85) | 8 (15) | ||
Subgroup | 5 (9) | 48 (91) | ||
7. | Conclusion | 61 (100) | 0 (0) | |
8. | Introduction | 61 (100) | 0 (0) | |
Methods | ||||
9. | Searching | |||
Search Terms | 61 (100) | 0 (0) | ||
Sources | ||||
Electronic Databases | 61 (100) | 0 (0) | ||
MEDLINE | 61 (100) | 0 (0) | ||
EMBASE | 32 (52) | 29 (48) | ||
CENTRAL | 52 (85) | 9 (15) | ||
CINAHL | 26 (43) | 35 (57) | ||
Others | 33 (54) | 28 (46) | ||
Online Registry of Studies | 9 (15) | 52 (85) | ||
Personal Files | 8 (13) | 53 (87) | ||
Citations List | 53 (87) | 8 (13) | ||
Hand Search of Journals | 21 (34) | 40 (66) | ||
Proceedings | 47 (77) | 14 (23) | ||
Authors Contacts | 10 (16) | 51 (84) | ||
Experts Contact | 26 (43) | 35 (57) | ||
Manufacturers | 2 (3) | 59 (97) | ||
Restrictions | ||||
Year | 2 (3) | 58 (95) | 1 (2) | |
Publication Status | 5 (8) | 21 (35) | 35 (57) | |
Language | 2 (3) | 38 (62) | 21 (34) | |
10. | Selection Criteria | 61 (100) | 0 (0) | |
11. | Validity Assessment | 48 (79) | 13 (21) | |
12. | Data Abstraction in Duplicate and Independent | 58 (95) | 3 (5) | |
13. | Clinical Heterogeneity | 8 (13) | 53 (87) | |
14. | Quantitative Data Synthesis | |||
Principal Measure of Effect | 52 (85) | 9(15) | ||
Method of Combining Data | 40 (66) | 21 (34) | ||
Handling Missing Data | 43 (70) | 18 (30) | ||
Statistical Heterogeneity | 13 (21) | 47 (77) | 1 (2) | |
Rationale for Subgroups | 7 (11) | 45 (74) | 9 (15) | |
Assessment of Publication Bias | 0 (0) | 61 (100) | ||
Results | ||||
15. | Trial flow | 0 (0) | 61 (100) | |
16. | Study characteristics | 53 (100) | 0 (0) | |
17. | Quantitative data synthesis | |||
Agreement on selection | 3 (5) | 57 (93) | 1 (2) | |
Agreement on validity | 2 (4) | 51 (94) | 1 (2) | |
Summary result | 50 (94) | 1 (2) | 2 (4) | |
Present data needed to calculate effect size | 52 (98) | 1 (2) | ||
18. | Discussion | |||
Summarize key findings | 60 (98) | 1 (2) | ||
Discuss internal and external validity | 32 (53) | 5 (8) | 24 (39) | |
Discuss potential biases | 3 (5) | 53 (87) | 5 (8) | |
Suggest future research | 61 (100) | 0 (0) |